(Circulation. 1995;91:2245-2263.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Pharmacology (A.E.S., S.M.D., A.L.W.) and Medicine (J.C.), College of Physicians and Surgeons, Columbia University, New York, NY, and the Department of Medicine (B.W.), Justus Liebig University, Giessen, Germany.
Correspondence to James Coromilas, MD, Department of Medicine, College of Physicians and Surgeons, 630 West 168th St, New York, NY 10032.
Background The class IC antiarrhythmic drug flecainide has been shown to be ineffective for the treatment of ventricular arrhythmias in some patients who have had a prior myocardial infarction and sometimes even provoke arrhythmias (proarrhythmic effect). Since some ventricular tachycardias may be caused by anisotropic reentry, we determined the effects of flecainide on this mechanism for reentry in infarcted canine hearts in order to determine possible causes for its clinical effects.
Methods and Results The effects of flecainide were determined on ventricular tachycardia induced by programmed electrical stimulation in dogs with healing myocardial infarction 4 days after coronary artery occlusion. Activation in the reentrant circuits causing tachycardia was mapped with a 196-channel computerized mapping system. We found that flecainide converted inducible unsustained ventricular tachycardia to inducible sustained ventricular tachycardia by modifying conduction in the reentrant circuit. In general, by slowing conduction, the reentrant wave front did not block after flecainide, leading to perpetuation of reentrant excitation. When sustained ventricular tachycardia could be induced before the drug, flecainide prolonged the coupling interval of premature impulses necessary to induce tachycardia by lengthening the line of block and slowing conduction around it. Flecainide also slowed the rate of the tachycardia but did not terminate it. The anisotropic reentrant circuits were modified so that the central common pathway of "figure-of-eight" circuits was narrowed and lengthened due to extension of the lines of block that bounded the pathways. Extension of the lines of block resulted from depression of conduction in the direction transverse to the long axis of the myocardial fiber bundles caused by flecainide. Flecainide also slowed conduction in the longitudinal direction in part of the circuits. The depressant effects of flecainide on both longitudinal and transverse anisotropic conduction were quantified by pacing from the center of the electrode array and it was found, contrary to predictions, that transverse conduction was depressed as much as longitudinal conduction.
Conclusions Flecainide slows conduction in both the longitudinal and transverse direction relative to the orientation of the myocardial fibers. This enables sustained reentry to occur more easily. Flecainide does not cause conduction block in crucial regions of reentrant circuits (central common pathway) and therefore does not prevent reentrant tachycardia in healing infarcts.
Key Words: ventricles tachycardia myocardial infarction reentry
This article has been cited by other articles:
![]() |
R. Veeraraghavan and S. Poelzing Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge Cardiovasc Res, March 1, 2008; 77(4): 749 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuda, S. S. Davies, T. Nakajima, B.-H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M. E. Anderson, P. A. Boyden, P. C. Viswanathan, et al. Oxidative Mediated Lipid Peroxidation Recapitulates Proarrhythmic Effects on Cardiac Sodium Channels Circ. Res., December 9, 2005; 97(12): 1262 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu and J. N. Weiss Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1692 - H1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, W. Dun, and P. A. Boyden Can PKA activators rescue Na+ channel function in epicardial border zone cells that survive in the infarcted canine heart? Cardiovasc Res, November 1, 2004; 64(2): 260 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu, H. S. Karagueuzian, A. Garfinkel, and J. N. Weiss Effects of Na+ channel and cell coupling abnormalities on vulnerability to reentry: a simulation study Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1310 - H1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Berul Electrophysiological phenotyping in genetically engineered mice Physiol Genomics, May 13, 2003; 13(3): 207 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Coromilas, C. Costeas, B. Deruyter, S. M. Dillon, N. S. Peters, and A. L. Wit Effects of Pinacidil on Electrophysiological Properties of Epicardial Border Zone of Healing Canine Infarcts: Possible Effects of KATP Channel Activation Circulation, May 14, 2002; 105(19): 2309 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nitta, M. Mitsuno, C. K. Rokkas, R. Lee, R. B. Schuessler, and J. P. Boineau Cryoablation of ventricular tachycardia guided by return cycle mapping after entrainment J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0249 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cabo, H. Schmitt, and A. L. Wit New Mechanism of Antiarrhythmic Drug Action : Increasing L-Type Calcium Current Prevents Reentrant Ventricular Tachycardia in the Infarcted Canine Heart Circulation, November 7, 2000; 102(19): 2417 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yashima, T. Ohara, J.-M. Cao, Y.-H. Kim, M. C. Fishbein, W. J. Mandel, P.-S. Chen, and H. S. Karagueuzian Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2124 - H2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pu, J. R. Balser, and P. A. Boyden Lidocaine Action on Na+ Currents in Ventricular Myocytes From the Epicardial Border Zone of the Infarcted Heart Circ. Res., August 24, 1998; 83(4): 431 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Kirchhof, C. L. Fabritz, and M. R. Franz Postrepolarization Refractoriness Versus Conduction Slowing Caused by Class I Antiarrhythmic Drugs : Antiarrhythmic and Proarrhythmic Effects Circulation, June 30, 1998; 97(25): 2567 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Peters, J. Coromilas, M. S. Hanna, M. E. Josephson, C. Costeas, and A. L. Wit Characteristics of the Temporal and Spatial Excitable Gap in Anisotropic Reentrant Circuits Causing Sustained Ventricular Tachycardia Circ. Res., February 9, 1998; 82(2): 279 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Costeas, N. S. Peters, B. Waldecker, E. J. Ciaccio, A. L. Wit, and J. Coromilas Mechanisms Causing Sustained Ventricular Tachycardia With Multiple QRS Morphologies : Results of Mapping Studies in the Infarcted Canine Heart Circulation, November 18, 1997; 96(10): 3721 - 3731. [Abstract] [Full Text] |
||||
![]() |
C. Cabo, B. Deruyter, J. Coromilas, and A. L. Wit Mechanisms for Absence of Inverse Relationship Between Coupling Intervals of Premature Impulses Initiating Reentrant Ventricular Tachycardia and Intervals Between Premature and First Tachycardia Impulses Circulation, November 4, 1997; 96(9): 3136 - 3147. [Abstract] [Full Text] |
||||
![]() |
K. T. Cragun, S. B. Johnson, and D. L. Packer ß-Adrenergic Augmentation of Flecainide-Induced Conduction Slowing in Canine Purkinje Fibers Circulation, October 21, 1997; 96(8): 2701 - 2708. [Abstract] [Full Text] |
||||
![]() |
N. S. Peters, J. Coromilas, N. J. Severs, and A. L. Wit Disturbed Connexin43 Gap Junction Distribution Correlates With the Location of Reentrant Circuits in the Epicardial Border Zone of Healing Canine Infarcts That Cause Ventricular Tachycardia Circulation, February 18, 1997; 95(4): 988 - 996. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |